GLIOLA

Live / Applied — First extension granted (statement of use) (as of 26 Nov 2025)

What this means for you

Not registered yet, but its 12 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98496546
Mark type
Stylized text
Filed
12 Apr 2024
Published for opposition
01 Apr 2025
Attorney of record
Hayoon Kane

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of infectious diseases; nutritive substances for micro-organisms for medical use; cellular function activating agents for medical purposes; dietetic substances being dietetic foods adapted for medical use; pharmaceuticals preparations for reagents to identify disease progression when administered during surgery; dermatological pharmaceutical products; Stem cells for medical use and purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues grown from stem cells

Owner

Prosecution history

  • 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 26 Nov 2025 — SOU EXTENSION 1 GRANTED
  • 26 Nov 2025 — SOU EXTENSION 1 FILED
  • 26 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 01 Apr 2025 — PUBLISHED FOR OPPOSITION
  • 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 06 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 29 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 28 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 28 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 01 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 01 Nov 2024 — NON-FINAL ACTION E-MAILED
  • 01 Nov 2024 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy